ArticleFrontiers in genetics2026
Bidirectional association between zinc and liver cirrhosis: evidence from mendelian randomization and clinical validation.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: It remains unclear whether low blood zinc levels in cirrhosis patients are a cause or a consequence of the disease. Methods: Seven blood metals (calcium, iron, magnesium, phosphorus, copper, selenium, zinc) were assessed using two-sample Mendelian randomization (MR). We performed reverse MR analysis on the positive results and subsequently evaluated the zinc findings in a cohort of 137 cirrhosis patients. Results: MR analysis revealed that higher genetically predicted zinc levels were associated with an increased cirrhosis risk (OR = 1.24, 95% CI = [1.04, 1.46], p = 0.014). No significant associations were found for other metals. Reverse MR analysis revealed no reverse causality between liver cirrhosis and zinc. In the clinical cohort, 60.5% of patients had hypozincemia, and zinc levels declined progressively with worsening Child-Pugh score (r = - 0.615, p < 0.01). Additionally, a positive correlation was observed between serum zinc levels and albumin (ALB). In contrast, zinc levels were inversely associated with total bilirubin (TBIL), prothrombin time (PT), and international normalized ratio (INR). Conclusion: Genetically higher zinc levels predispose individuals to cirrhosis, whereas advanced cirrhosis induces zinc deficiency. These bidirectional findings suggest that zinc exerts opposite effects at different disease stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.